These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29987895)

  • 1. Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.
    Kim YJ; Yoo JE; Jeon Y; Chong JU; Choi GH; Song DG; Jung SH; Oh BK; Park YN
    Int J Cancer; 2018 Dec; 143(12):3155-3168. PubMed ID: 29987895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
    Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
    Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
    Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
    Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
    Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML
    Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
    Chen YL; Jeng YM; Chang CN; Lee HJ; Hsu HC; Lai PL; Yuan RH
    Int J Surg; 2014; 12(7):659-65. PubMed ID: 24866078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Patterns of HBV Integration and
    Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
    Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
    Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
    Ko E; Seo HW; Jung ES; Kim BH; Jung G
    Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
    Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
    Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter.
    Zhu R; Zhang JS; Zhu YZ; Fan J; Mao Y; Chen Q; Zhu HG
    Histol Histopathol; 2011 Jan; 26(1):23-35. PubMed ID: 21117024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
    Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
    Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
    You X; Liu F; Zhang T; Lv N; Liu Q; Shan C; Du Y; Kong G; Wang T; Ye L; Zhang X
    Oncogene; 2014 Jan; 33(4):449-60. PubMed ID: 23318446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.